Verona Pharma plc - American Depositary Shares (VRNA) Covered Calls

You can sell covered calls on Verona Pharma plc - American Depositary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for VRNA (prices last updated Tue 4:16 PM ET):

Verona Pharma plc - American Depositary Shares (VRNA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
38.09 +3.15 37.50 38.50 1.4M - 0.0
Covered Calls For Verona Pharma plc - American Depositary Shares (VRNA)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 40 1.35 37.15 3.6% 41.1%
Jan 17 40 2.50 36.00 6.9% 42.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on develops and commercializes therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine (RPL554), is an inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The formulations of ensifentrine are under development for the treatment chronic obstructive pulmonary disease (COPD): nebulized ensifentrine is in Phase 2b clinical development for the maintenance treatment of COPD; and a dry powder inhaler and a pressurized metered-dose inhaler. The company also focuses on developing ensifentrine for the treatment of cystic fibrosis and asthma. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.